JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Setting

Order Through VWR & Receive a FREE Sample

Support: [email protected]

Track Your Order

Home
Bioactive Compounds
Signaling Pathways

Signaling Pathways

A4152 BMS-911543

Target: JAK

Summary: JAK2 inhibitor,selective small molecule

≥43.3 mg/mL
A2614 Bortezomib (PS-341)
52 Citation

Target: Proteasome

Summary: proteasome inhibitor

insoluble in EtOH; insoluble in H2O; ≥19.21 mg/mL
A1909 BIX 01294
2 Citation

Target: G9a

Summary: G9a and GLP inhibitor

≥24.45 mg/mL
A1910 Bromodomain Inhibitor, (+)-JQ1
66 Citation

Target: Bromodomains

Summary: BET bromodomain inhibitor

≥22.85 mg/mL
A4304 Rosiglitazone
4 Citation

Summary: Potent PPARγ agonist

insoluble in EtOH; insoluble in H2O; ≥17.85 mg/mL
A4357 Dorzolamide HCl

Summary: Carbonic anhydrase inhibitor

insoluble in EtOH; ≥13 mg/mL
A4371 Ferrostatin-1 (Fer-1)
57 Citation

Target: Ferroptosis

Summary: ferroptosis inhibitor

≥149 mg/mL
A4393 Paclitaxel (Taxol)
27 Citation

Target: Microtubules/Tubulins

Summary: microtubule depolymerization inhibitor

≥85.6 mg/mL
A3151 Alarelin Acetate

Summary: Synthetic GnRH agonist

≥128.7 mg/mL
A3195 Asunaprevir (BMS-650032)
5 Citation

Summary: NS3 protease inhibitor

≥37.41 mg/mL